LEARNER OBJECTIVES
At the completion of this chapter, the learner will be able to:
Section 1: Crohn's Disease
1.0 Define Crohn's disease.
1.1 Explain the pathology of Crohn's disease.
1.2 Identify the anatomic distribution of Crohn's disease.
1.3 Describe the epidemiology of Crohn's disease throughout the
world.
1.4 Explain the etiology of Crohn's disease.
1.5 Describe the clinical features of Crohn's disease.
1.6 Discuss the following complications as related to Crohn's
disease:
1.6.1 Small bowel obstruction
1.6.2 Fistulas and fissures
1.6.3 Perforation
1.6.4 Gastrointestinal blood
loss
1.6.5 Malignant neoplasms
1.6.6 Extraintestinal
manifestations
1.7 Describe the diagnosis process for Crohn's disease, including
the
following:
1.7.1 Laboratory investigations
1.7.2 Radiologic findings
1.7.3 Histologic examination
1.8 Explain treatment therapy for Crohn's disease, including the
following:
1.8.1 Supportive therapy
1.8.2 Nutritional therapy
1.8.3 Drug therapy
1.8.3.1
Corticosteroids
1.8.3.2
Mesalamine
1.8.3.3
Immunosuppressive agents
1.8.3.4
Metronidazole
1.8.4 Surgical treatment
1.8.5 Treatment for maintenance
or remission of inactive Crohn's
disease
1.8.6 New therapeutic approaches
Section 2: Ulcerative Colitis
2.0 Define ulcerative colitis.
2.1 Explain the pathophysiology of ulcerative colitis.
2.2 Identify the clinical features of ulcerative colitis, including
the
following:
2.2.1 Severe ulcerative colitis
2.2.2 Moderate ulcerative
colitis
2.3.2 Mild ulcerative colitis
2.3 Describe the diagnosis process for ulcerative colitis, including
the
following:
2.3.1 Physical examination
2.3.2 Laboratory investigations
2.3.3 Endoscopic findings
2.3.4 Radiologic findings
2.4 Describe the method for distinguishing between ulcerative
colitis and
Crohn's disease of the colon (Crohn's
colitis).
2.5 Discuss therapy for ulcerative colitis, including the
following:
2.5.1 Reasons for
hospitalization
2.5.2 Supportive therapy
2.5.3 Nutritional therapy
2.5.4 Drug therapy
2.5.4.1
Corticosteroids
2.5.4.2
Mesalamine derivatives
2.5.4.3
Immunosuppressive agents
2.5.4.4
Metronidazole
2.5.5 Surgical therapy
2.6 Describe the following complications as related to ulcerative
colitis:
2.6.1 Minor local complications
2.6.2 Major local complications
2.6.2.1
Toxic megacolon
2.6.2.2
Cancer of the colon
2.6.2.3
Colonic stricture
2.6.2.4
Massive colonic hemorrhage
2.6.3 Systemic complications
2.6.3.1
Hepatocellular disease
2.6.3.2
Hematologic abnormalities
2.6.3.3
Joint manifestations
2.6.3.4
Skin manifestations
2.6.3.5
Ocular manifestations
LEARNER WORKBOOK
EXERCISE 1
1.1 What is Crohn's disease?
Answer
(section 1, p306)
1.2 Briefly describe the pathology of Crohn's
disease.
Answer
(section 1.1, p306-307)
1.3 Patients' with Crohn's disease can
be divided into three categories.
What are these and what is the
percentage of occurrence for each?
Answer
(section 1.2, p307-308)
1.4 What are the clinical features of
Crohn's disease?
Answer
(section 1.5, p309-310)
1.5 List five mechanisms responsible for
malabsorption and malnutrition in
Crohn's disease.
Answer
(table 3, p310)
1.6 Briefly describe five complications
associated with Crohn's disease.
Answer
(section 1.6, p312-314)
1.7 How is Crohn's disease diagnosed?
Briefly discuss differential
diagnosis, laboratory
investigations, radiologic findings, and histologic
examination.
Answer
(section 1.7, p314-316)
1.8 Briefly discuss drug therapy for
Crohn's disease, including the following:
1.8.1 Corticosteroids
1.8.2 Mesalamine
1.8.3 Immunosuppressive agents
1.8.4 Metronidazole
Answer
(section 1.8, p319-321)
EXERCISE 2
2.1 What is ulcerative colitis?
Answer
(section 2, p323)
2.2 Briefly describe the pathophysiology of
ulcerative colitis.
Answer
(section 2.1, p323-324)
2.3 What are the clinical features of
ulcerative colitis?
Answer
(section 2.2, p324-325)
2.4 Ulcerative colitis can be classified
according to grade of clinical
severity: severe, moderate, or
mild. Briefly discuss each.
Answer
(section 2.2, p325-327)
2.5 Complete the following table :
| Endoscopic
grading of activity in ulcerative colitis: |
|
| Activity |
Appearance |
| Quiescent |
| Mildly
active |
| Moderately
active |
| Severe |
Answer
(table 8, p328)
2.6 What are the indications for colonoscopy?
Answer
(table 9, p329)
2.7 Describe the method for distinguishing
between ulcerative colitis and
Crohn's disease of the colon.
Answer
(table 11, p333)
2.8 List three reasons for hospitalization of a
patient with ulcerative colitis.
Answer
(section 2.5.1, p330, 333)
2.9 Briefly discuss drug therapy for
ulcerative colitis, including the following:
2.9.1 Corticosteroids
2.9.2 Mesalamine derivatives
2.9.3 Immunosuppressive agents
Answer
(section 2.5.4, p334-337)
2.10 Distinguish between minor local and major local complications
in
ulcerative colitis.
Answer
(section 2.6, p338-342)
2.11 Describe five systemic
complications of ulcerative colitis.
Answer
(section 2.6.3, p342-344)